ADPT
Adaptive Biotechnologies Corp
NASDAQ: ADPT · HEALTHCARE · BIOTECHNOLOGY
$13.53
-3.63% today
Updated 2026-04-29
Market cap
$2.16B
P/E ratio
—
P/S ratio
7.80x
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$8 – $21
Volume
1.9M
Adaptive Biotechnologies Corp (ADPT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-21.50%
Operating margin
-17.80%
ROE
-27.80%
ROA
-6.79%
Debt/equity
1.28x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $38.45M | $-42.83M | 59.22% | -115.68% | -111.40% |
| 2018 | $55.66M | $-46.45M | 64.67% | -89.39% | -83.44% |
| 2019 | $85.07M | $-68.61M | 73.82% | -92.15% | -80.65% |
| 2020 | $98.38M | $-146.23M | 77.10% | -155.33% | -148.63% |
| 2021 | $154.34M | $-207.28M | 68.06% | -135.39% | -134.30% |
| 2022 | $185.31M | $-200.19M | 68.75% | -108.03% | -108.03% |
| 2023 | $170.28M | $-225.25M | 55.63% | -133.33% | -132.29% |
| 2024 | $178.96M | $-159.49M | 59.72% | -90.83% | -89.12% |
| 2025 | $276.98M | $-59.50M | 74.24% | -20.62% | -21.48% |